Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients with primary PC, such as mesothelioma, or seco...

Descripción completa

Detalles Bibliográficos
Autores principales: VALLEJO, JAIRO SEBASTIÁN ASTUDILLO, QUEIROZ, FABIO LOPES DE, LACERDA, ANTÔNIO, FRANÇA, PAULO ROCHA, COSTA, BRENO XAIA MARTINS DA, PAIVA, RODRIGO ALMEIDA, GARCIA, SILVÉRIO LEONARDO MACEDO, SILVA, SERGIO BOTREL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Colégio Brasileiro de Cirurgiões 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508679/
https://www.ncbi.nlm.nih.gov/pubmed/37075463
http://dx.doi.org/10.1590/0100-6991e-20233421-en

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508679/
https://www.ncbi.nlm.nih.gov/pubmed/37075463
http://dx.doi.org/10.1590/0100-6991e-20233421-en

Ejemplares similares